Activation of distinct P2Y receptor subtypes stimulates insulin secretion in MIN6 mouse pancreatic β cells
- 1 May 2010
- journal article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 79 (9) , 1317-1326
Abstract
No abstract availableKeywords
This publication has 49 references indexed in Scilit:
- Quantification of recombinant and platelet P2Y1 receptors utilizing a [125I]-labeled high-affinity antagonist 2-iodo-N6-methyl-(N)-methanocarba-2′-deoxyadenosine-3′,5′-bisphosphate ([125I]MRS2500)Pharmacological Research, 2010
- Evidence for the possible involvement of the P2Y6 receptor in Ca2+ mobilization and insulin secretion in mouse pancreatic isletsPurinergic Signalling, 2008
- Attenuation of apoptosis in vitro and ischemia/reperfusion injury in vivo in mouse skeletal muscle by P2Y6 receptor activationPharmacological Research, 2008
- Development of selective agonists and antagonists of P2Y receptorsPurinergic Signalling, 2008
- Synthesis and potency of novel uracil nucleotides and derivatives as P2Y2 and P2Y6 receptor agonistsBioorganic & Medicinal Chemistry, 2008
- Thioredoxin-Interacting ProteinDiabetes, 2008
- Integration of P2Y receptor-activated signal transduction pathways in G protein-dependent signalling networksPurinergic Signalling, 2006
- (N)‐methanocarba‐2MeSADP (MRS2365) is a subtype‐specific agonist that induces rapid desensitization of the P2Y1 receptor of human plateletsJournal of Thrombosis and Haemostasis, 2006
- Suppressor mechanism of serum thymic factor on tumor necrosis factor-α-induced apoptosis in the mouse pancreatic β-cell lineBiochemical and Biophysical Research Communications, 2003
- Gliclazide protects pancreatic β-cells from damage by hydrogen peroxideBiochemical and Biophysical Research Communications, 2003